Document is current
Any future updates will be listed below
-
Authors
Marks, John H.
Jobst, Michael A.
Keller, Deborah S.
Lagares-Garcia, Jorge A.
Schoonyoung, Henry P.
Farritor, Shane M.
Oleynikov, Dmitry
-
Funding
Funding for this research was provided by:
VIRTUAL INCISION
- License Information
-
More Information
Article History
Received: 20 April 2024
Accepted: 1 August 2024
First Online: 13 September 2024
Declarations
:
: Virtual Incision Corporation designed and funded the IDE study and analyzed the data as part of an FDA submission. Dr. Michael Jobst is a paid consultant for Virtual Incision Corporation. Shane Farritor, PhD and Dr. Dmitry Oleynikov are founders of Virtual Incision Corporation, the manufacturer of the device described in this manuscript. Drs. Marks, Lagares-Garcia, and Schoonyoung all served as principal investigators in the IDE study. Dr. Keller has no conflicts of interest to disclose.
